With this guidance, we expect that more sponsors will adopt this study design in oncology trials and beyond the oncology trials.
The dose cohort expansion study design completely changed the traditional phased approaches for clinical trials for drug development. The phases I, II, III, IV are no longer critical.
No comments:
Post a Comment